Seres Therapeutics ( (MCRB) ) has shared an announcement.
On February 22, 2025, Seres Therapeutics announced that Lisa von Moltke, M.D. will resign from her role as Executive Vice President and Chief Medical Officer, effective March 14, 2025. Dr. von Moltke is set to join another U.S. biopharmaceutical company as Chief Medical Officer and Head of Research and Development, focusing on autoimmune diseases, reflecting her professional interest.
More about Seres Therapeutics
YTD Price Performance: -10.71%
Average Trading Volume: 1,917,235
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $128.1M
See more data about MCRB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com